You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 154 No. 7, 11 April 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review Articles
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Helicobacter pylori

M. Brian Fennerty, MD

Arch Intern Med. 1994;154(7):721-727.


Abstract

Helicobacter pylori is the cause of chronic active gastritis. It is integral to the pathogenesis of peptic ulcer disease and is epidemiologically linked to gastric cancer and lymphoma. Helicobacter pylori can be detected through a variety of invasive (urease testing, culture, or histologic diagnosis of endoscopic biopsies) and noninvasive (urease breath tests, serologic tests) diagnostic tests. It is now appropriate to detect and eradicate H pylori in patients with a peptic ulcer as the natural history of peptic ulcer disease is then markedly improved. At this time, there is no role for H pylori eradication in the prevention of gastric cancer; however, this concept is being actively investigated. There is no indication to treat patients who have H pylori and nonulcer dyspepsia or gastritis because eradication does not reliably affect their symptoms. Current regimens for eradication include bismuth, antibiotics, and antisecretory agents. Complex and poorly tolerated regimens (triple therapy) may no longer be necessary, as simpler regimens (omeprazole and amoxicillin or clarithromycin) appear to be as effective and better tolerated.

(Arch Intern Med. 1994;154:721-727)



Author Affiliations

From the Section of Gastroenterology, Department of Medicine, Arizona Health Sciences Center, Tucson.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Impact of Helicobacter pylori Infection on Gastric Cancer Incidence in a General Japanese Population: The Hisayama Study
Yamagata et al.
Arch Intern Med 2000;160:1962-1968.
ABSTRACT | FULL TEXT  

Effectiveness of Helicobacter pylori Therapies in a Clinical Practice Setting
Fennerty et al.
Arch Intern Med 1999;159:1562-1566.
ABSTRACT | FULL TEXT  

Diagnostic tests for Helicobacter pylori • Reply
KOUNTOURAS and WALT
Gut 1998;42:899c-899.
FULL TEXT  

Treatment of Helicobacter pylori Infection
de Boer and Driessen
Arch Intern Med 1995;155:330-331.
ABSTRACT  

The role of biomedical research in health care reform
Kirschner et al.
Science 1994;266:49-51.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.